Blindness following hydrogen peroxide ingestion and recovery with hyperbaric oxygen therapy. | Canada Hyperbarics Skip to main content
Clinical Study Toxicology reports 2025

Blindness following hydrogen peroxide ingestion and recovery with hyperbaric oxygen therapy.

Engelmann AR, Pargalava N, Sadun AA — Toxicology reports, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported the first case of blindness caused by cerebral infarctions due to oxygen emboli from hydrogen peroxide ingestion, which was successfully treated with hyperbaric oxygen therapy.

What They Found

A patient who ingested commercial-grade (35%) hydrogen peroxide developed profound vision loss, with imaging revealing gastric wall edema, gas in the portal venous system, and multifocal embolic infarcts along the visual pathway. Hyperbaric oxygen therapy led to a rapid improvement in visual acuity from hand motion to 20/20 and near-total resolution of visual field loss, even when initiated over 24 hours after symptom onset.

What This Means for Canadian Patients

Canadian patients should understand the severe dangers of ingesting commercial-grade hydrogen peroxide, which can lead to profound vision loss. This case highlights hyperbaric oxygen therapy as a potentially effective treatment for such vision impairment, even with delayed intervention.

Canadian Relevance

This study has no direct Canadian connection as it reports a single case from outside Canada.

Study Limitations

The primary limitation of this study is its nature as a single case report, which restricts the generalizability of its findings.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Neurological
Source Pubmed
PubMed ID 40125300
Year Published 2025
Journal Toxicology reports

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.